CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 61 filers reported holding CARDIFF ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $71,646 | +41554.7% | 48,739 | -53.1% | 0.00% | – |
Q1 2023 | $172 | -12.7% | 103,942 | -26.2% | 0.00% | – |
Q4 2022 | $197 | -99.9% | 140,767 | -29.5% | 0.00% | – |
Q3 2022 | $308,000 | -64.4% | 199,787 | -49.2% | 0.00% | -100.0% |
Q2 2022 | $866,000 | +22.5% | 393,603 | +38.1% | 0.00% | – |
Q1 2022 | $707,000 | -71.9% | 284,994 | -32.0% | 0.00% | -100.0% |
Q4 2021 | $2,517,000 | +196.5% | 418,880 | +228.5% | 0.00% | 0.0% |
Q3 2021 | $849,000 | -71.6% | 127,498 | -60.5% | 0.00% | -50.0% |
Q1 2021 | $2,991,000 | +419.3% | 322,962 | +908.0% | 0.00% | – |
Q4 2020 | $576,000 | -56.8% | 32,041 | -65.9% | 0.00% | -100.0% |
Q3 2020 | $1,333,000 | – | 93,953 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 120,600 | $299,000 | 0.32% |
Artal Group S.A. | 750,000 | $1,860,000 | 0.08% |
Eventide Asset Management | 1,467,922 | $3,640,000 | 0.06% |
Atom Investors LP | 33,798 | $84,000 | 0.04% |
XTX Topco Ltd | 25,154 | $62,000 | 0.03% |
ELKHORN PARTNERS LIMITED PARTNERSHIP | 19,000 | $47,000 | 0.02% |
Engineers Gate Manager LP | 245,567 | $609,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 63,749 | $158,000 | 0.02% |
KENNEDY CAPITAL MANAGEMENT LLC | 168,902 | $419,000 | 0.01% |
Walleye Capital LLC | 123,305 | $306,000 | 0.01% |